Efficacy and Safety of Oral OPS-2071 in Participants With Crohn's Disease Showing Symptoms of Active Inflammation
Clinical trial NCT03850509 · TERMINATED
Trial details
- NCT number
- NCT03850509
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-25
- Primary completion
- 2020-05-22
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.